1. Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, et al. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infect Dis 2020;20:427. 2. Baghchechi M, Dunn J, Jaipaul N, Jacob SE. Art of prevention: Life in the time of coronavirus. Int J Womens Dermatol 2020;6:137-141. https://doi.org/10.1016/j.ijwd.2020.03.046 3. Badrfam R, Zandifar A. Coronavirus disease 2019 in Iran: the need for more attention to primary health care. Public Health 2020;182:187. https://doi.org/10.1016/j.puhe.2020.03.010 4. Abdi M. Coronavirus disease 2019 (COVID-19) pandemic in Iran: Actions and problems. Infect Control Hosp Epidemiol 2020;41:754-755. https://doi.org/10.1017/ice.2020.86 5. Mamishi S, Heydari H, Aziz-Ahari A, Shokrollahi MR, Pourakbari B, Mahmoudi S, et al. Novel coronavirus disease 2019 (COVID-19) pandemic in children in Iran: Atypical CT manifestations and mortality risk of severe COVID-19 infection. J Microbiol Immunol Infect 2020;S1684-1182:30177-8. https://doi.org/10.1016/j.jmii.2020.07.019 6. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available at: https://covid19.who.int/table. Data last updated: 2020/12/13, 4:58pm CET 7. Khosravi A, Chaman R, Rohani-Rasaf M, Zare F, Mehravaran S, Emamian MH. The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud, Iran. Epidemiol Infect 2020;148:e115. https://doi.org/10.1017/S0950268820001247 [DOI:10.1186/s12879-020-05128-x]

2. Maleki M, Mahmoudi MR, Heydari MH, Pho KH. Modeling and forecasting the spread and death rate of coronavirus (COVID-19) in the world using time series models. Chaos Solitons Fractals 2020;140:110151. [DOI:10.1016/j.chaos.2020.110151]

3. Pourghasemi HR, Pouyan S, Heidari B, Farajzadeh Z, Fallah Shamsi SR, Babaei S, et al. Spatial modeling, risk mapping, change detection, and pandemic trend analysis of coronavirus (COVID-19) in Iran (days between February 19 and June 14, 2020). Int J Infect Dis 2020;98:90-108. [DOI:10.1016/j.ijid.2020.06.058]

4. Heydari, K, Rismantab S, Shamshirian A, Lotfi, P, Shadmehri N, Houshmand P, et al. Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis. medRxiv 2020. [DOI:10.1101/2020.03.26.20044057]

5. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect 2020;80:656-665. [DOI:10.1016/j.jinf.2020.03.041]

6. Sabri A, Davarpanah AH, Mahdavi A, Abrishami A, Khazaei M, Heydari S, et al. Novel coronavirus disease 2019: predicting prognosis with a computed tomography-based disease severity score and clinical laboratory data. Pol Arch Intern Med 2020;130:629-634. [DOI:10.20452/pamw.15422]

7. World Health Organization. WHO COVID-19 Case definition. updated in Public health surveillance for COVID-19, published 7 August 2020, Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2020.1

8. Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol 2020;127:104378. [DOI:10.1016/j.jcv.2020.104378]

9. Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin Infect Dis 2020;71:1547-1551. [DOI:10.1093/cid/ciaa198]

10. Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. [DOI:10.1016/S0140-6736(20)30183-5]

11. Ki M; Task Force for 2019-nCoV. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol Health 2020;42:e2020007. [DOI:10.4178/epih.e2020007]

12. Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis 2020;71:706-712. [DOI:10.1093/cid/ciaa199]

13. Hassan S, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus 2020;12: e7355. [DOI:10.7759/cureus.7355]

14. Zhao XY, Xu XX, Yin HS, Hu QM, Xiong T, Tang YY, et al. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. BMC Infect Dis 2020;20:311. [DOI:10.1186/s12879-020-05010-w]

15. Yu X, Yang R. COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses 2020 ;14:474-475. [DOI:10.1111/irv.12743]

16. Dai H, Zhang X, Xia J, Zhang T, Shang Y, Huang R, et al. High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China. Int J Infect Dis 2020;95:106-112. [DOI:10.1016/j.ijid.2020.04.003]